According to Future Market Insights (FMI), the Global Pressure Infusion Bags Market was valued at around US$ 318.6 Million in 2022 and is predicted to reach US$ 494.5 Million by 2029, with a CAGR of 6.5%.
This growth is majorly driven by the increasing use of pressure infusion bags for rapid infusion of blood and drugs, in order to protect the end organ damage during traumatic conditions.
South Asia Continues to Hold Lucrative Opportunities
Regions such as North America and East Asia are expected to hold prominent market shares in terms of value. However, the South Asia market is expected to project lucrative growth in the global pressure infusion bags market over the forecast period of 2022 to 2029.
This growth is propelled by the rapid growth and development of healthcare infrastructure, especially trauma care units, intensive care units and ambulatory surgical centers in countries of South Asia that include India and ASEAN countries. The economic condition of these countries have been developing positively, thereby creating newer growth opportunities for the market players.
Macroeconomic factors such as growing population, increasing immunosuppressed patient population, and increase in the number of players along with strong distribution network and rapid development in the healthcare infrastructure have attracted the attention of manufactures to establish a firm collaboration with local distributors in South Asia.
Pressure Infusion Bags Market: Vendor Insights
The report highlights some of the prominent market players, who have established themselves as leaders in the global pressure infusion bags market. Some of the examples of key players in the global pressure infusion bags market are VBM Medizintechnik GmbH, ERKA, Smiths Medical (Smiths Group plc.), Friedrich Bosch GmbH & Co. KG, Biegler GmbH, SARSTEDT AG & Co. KG. Vyaire Medical Inc., Spengler SAS, Armstrong Medical, SunMed and Statcorp Medical
Pressure Infusion Bags Market by Category
- Reusable Pressure Infusion Bags
- Disposable Pressure Infusion Bags
- Above 3000cc
- Blood & Drug Infusion
- Invasive Pressure Monitoring Procedure
- Trauma-Induced Haemorrhage
- Obstetric Haemorrhage
- Coagulopathy during cardiopulmonary bypass
By End User:
- Out-patient facilities
- Long-term care centers